Teva Pharmaceutical Industries Ltd

Type: Company

Name: Teva Pharmaceutical Industries Ltd (Teva Pharmaceutical Industries LTD)

Fact Sheet: Fact Sheet for Teva Pharmaceutical Industries Ltd.

First reported 20 hours ago - Updated 20 hours ago - 1 reports

In Utah, nation confusion reigns over teen access to “morning after pill”

Every week it seems new, conflicting information surfaces about Plan B, who can buy the emergency contraceptive and where.In April, a Reagan-appointed federal judge issued an order to make the so-called "morning after" pill available over the counter ... [Published Salt Lake Tribune - 20 hours ago]

Entities: FDA Food & Drug Administration, Teva Pharmaceutical Industries Ltd, Gilford (United States), Cedar City (United States)

First reported May 17 2013 - Updated May 17 2013 - 1 reports

Amgen Inc

Worker injured in flash fire at California Amgen facility

A worker at an Amgen research facility in South San Francisco has been hospitalized after a "flash fire" involving hazardous materials. "There was a flash fire at the research facility there," spokeswoman Ashleigh Koss said. "There was an incident with ... [Published HazardEx - May 17 2013]

Entities: Amgen Inc, Workers, Sandoz, Teva Pharmaceutical Industries Ltd, Detonation

First reported May 17 2013 - Updated May 17 2013 - 1 reports

Good News For Health Care Stocks Part 2

Reuben is a member of The Motley Fool Blog Network -- entries represent the personal opinion of the blogger and are not formally edited.It isn't surprising that providing Medicaid coverage to lower-income residents of Oregon led to an increased use of ... [Published Motley Fool - May 17 2013]

Entities: Teva Pharmaceutical Industries Ltd, Health Care, Medicaid, Drugs

First reported May 17 2013 - Updated May 17 2013 - 1 reports

Merck & Co Inc

Bristol-Myers, Merck And Roche: R&D Finds Golden Pill, So Buy

We had great news today (Thursday), but the response was tepid. Rather than being disappointed or dismissing the news, here is why we should be excited at both the developments and the investment potential it opens up.Thursday (5/16), The Wall Street ... [Published Seeking Alpha - May 17 2013]

Entities: Merck & Co Inc, Bristol-Myers Squibb Company, Roche Holding AG, Drugs

First reported May 17 2013 - Updated May 17 2013 - 1 reports

FDA Food & Drug Administration

Teva treads lightly in morning-after controversy

An employee enters the Teva headquarters in North Wales, Montgomery County.Travel DealsThe recent controversy surrounding the morning-after contraceptive pill called Plan B One-Step has been argued in political, regulatory, and legal circles. But Teva ... [Published Philly.com - May 17 2013]

Entities: Teva Pharmaceutical Industries Ltd, FDA Food & Drug Administration, Kathleen Sebelius, Contraceptive

First reported May 16 2013 - Updated May 16 2013 - 1 reports

Teva Pharmaceutical Industries Ltd

Teva Pharmaceutical (TEVA) Showing Support Near $39.48 With 2.22% Dividend Yield

Teva Pharmaceutical Industries Ltd (NASDAQ: TEVA) closed Wednesday's trading session at $39.95. In the past year, the stock has hit a 52-week low of $36.63 and 52-week high of $42.83. Teva Pharmaceutical (TEVA) stock has been showing support around $39.48 ... [Published MarketIntelligenceCenter.com - May 16 2013]

Entities: Teva Pharmaceutical Industries Ltd, Dividend Yield

First reported May 15 2013 - Updated May 15 2013 - 5 reports

Alexza Pharmaceuticals Inc

Alexza Pharmaceuticals Has A Partner In Big Pharma, Now What?

Home » Blogs » Alexza Pharmaceuticals (ALXA) recently announced that it had struck a licensing deal with Teva Pharmaceuticals (TEVA) for commercialization of Adasuve in the U.S. The licensing and supply agreement for ADASUVE (loxapine) inhalation powder ... [Published BioPortfolio - May 15 2013]

Entities: Alexza Pharmaceuticals Inc, Big Pharma, Teva Pharmaceutical Industries Ltd, Loxapine

First reported May 14 2013 - Updated May 15 2013 - 2 reports

Actavis Said to Have Spurned $15 Billion Takeover Bid From Mylan

May 14 (Bloomberg) -- Actavis Inc. rejected a cash-and- stock offer from fellow generic drugmaker Mylan Inc. for $15 billion, deciding instead to pursue talks to take over Warner Chilcott Plc, said people familiar with the matter.The Mylan offer valued ... [Published La Repubblica - May 14 2013]

Entities: Actavis, Mylan Incorporated, Warner Chilcott plc, Takeover Bid, Teva Pharmaceutical Industries Ltd

First reported May 13 2013 - Updated May 14 2013 - 3 reports

Alexza Reports 2013 First Quarter Financial Results

/PRNewswire/ --$ Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) today reported financial results for the fiscal quarter March 31 , 2013.$ The net loss for the quarters ended March 31, 2013 and 2012, as reported in accordance with accounting principles generally ... [Published Barchart - May 14 2013]

Entities: Teva Pharmaceutical Industries Ltd, Alexza Pharmaceuticals Inc, Loxapine, United States

First reported May 14 2013 - Updated May 14 2013 - 2 reports

Teva Pharmaceutical Industries Limited to Present at the Bank of America Merrill Lynch 2013 Health Care Conference

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) will host a live audio webcast at the Bank of America Merrill Lynch 2013 Health Care Conference in Las Vegas, NV. Jon Congleton, Senior Vice President and General Manager, Global CNS will present on Wednesday, ... [Published BioSpace - May 14 2013]

Entities: Teva Pharmaceutical Industries Ltd, Bank of America Merrill Lynch, Health Care, Jon Congleton

First reported May 14 2013 - Updated May 14 2013 - 2 reports

Sanofi fined in Plavix generics dispute

* Sanofi fined 40.6 million euros * Fine follows complaint filed by Teva Sante * Sanofi may appeal decision, shares down 0.6 percent (Adds details, Sanofi comments, shares) By Dominique Vidalon and NoÃ«lle Mennella PARIS, May 14 (Reuters) - The French ... [Published Sharenet - May 14 2013]

Entities: Sanofi SA, Plavix, Teva Pharmaceutical Industries Ltd, Stocks, Dominique Vidalon

First reported May 14 2013 - Updated May 14 2013 - 2 reports

NIFEDIAC CC (Nifedipine) Tablet, Film Coated, Extended Release [TEVA PHARMACEUTICALS USA]

Updated Date: May 6, 2013 EST ... [Published DailyMed Drug Label Updates for the last seven ... - May 14 2013]

Entities: Nifedipine, Teva Pharmaceutical Industries Ltd

Quotes

"Whenever they’re buying something like that we want to be able to counsel the patient and make sure they understand the side effects and how to take it" he said

In Utah, nation confusion reigns over teen access to “morning after pill” [Published Salt Lake Tribune - 20 hours ago]

A worker at an Amgen research facility in South San Francisco has been hospitalized after a "flash fire" involving hazardous materials. "There was a flash fire at the researchresearch facility there" spokeswoman Ashleigh Koss said. "There was an incident with a flammable liquid." There was no report on the worker's condition

Worker injured in flash fire at California Amgen facility [Published HazardEx - May 17 2013]

"Their action, like that of many other companies before them, demonstrates that the pharmaceutical industry is not willing to see its drugs used to kill prisoners. Medicines are made to save and improve lives, not end them in executions. Departments of Correction in the US must take heed of this message."

UK firm halts sale of convulsion drug to Arkansas over death row use [Published Pharmaceutical Technology - May 17 2013]

...CEO Kenneth Frazier said, "Investing in our growth is in the best long-term interest of the company." Also, "We are committed to innovation as a strategy, and we believe that over the long-term, it will pay off." He really surprised Wall Street by saying that Merck would no longer be making long-term, multi-year earnings projections...

Bristol-Myers, Merck And Roche: R&D Finds Golden Pill, So Buy [Published Seeking Alpha - May 17 2013]

More Content

sort by: Date \| Relevance
In Utah, nation confusion reigns over teen acce... [Published Salt Lake Tribune - 20 hours ago]
The Franklin Institute Tops-Out the Nicholas an... [Published Citybizlist - May 18 2013]
Worker injured in flash fire at California Amge... [Published HazardEx - May 17 2013]
Good News For Health Care Stocks Part 2 [Published Motley Fool - May 17 2013]
UK firm halts sale of convulsion drug to Arkans... [Published Pharmaceutical Technology - May 17 2013]
Bristol-Myers, Merck And Roche: R&D Finds Golde... [Published Seeking Alpha - May 17 2013]
Teva treads lightly in morning-after controversy [Published Philly.com - May 17 2013]
Motorola, Saab, Nidec and other Leading Compani... [Published PR.com Press Releases - May 17 2013]
Billionaire Frost Props Up Opko’s Prolor Offer ... [Published BusinessWeek - May 16 2013]
Market Report / Technology shares, Teva pull TA... [Published Haaretz - May 16 2013]
Bayer Buys Herbal Medicine Maker [Published Mergers & Acquisitions - May 16 2013]
Ambit Biosciences (AMBI) IPO Prices at $8 [Published Street Insider - May 16 2013]
Thu: Mellanox and Teva lead market gains [Published Globes - May 16 2013]
Skin Cancer Linked to Reduced Alzheimer's Risk [Published Bioscience Technology Online - May 16 2013]
WSJ: Novartis sniffs around $16B offer for Actavis [Published FiercePharma - May 16 2013]
Sebelius Limited Fundraising For Health Law to ... [Published Bloomberg - May 16 2013]
Cell Cure Neurosciences awarded $1.5m Chief Sci... [Published Globes - May 16 2013]
Ambit Biosciences Announces Pricing of Initial ... [Published KSWT13 - May 16 2013]
Teva Pharmaceutical (TEVA) Showing Support Near... [Published MarketIntelligenceCenter.com - May 16 2013]
FDA Approves Over-The-Counter Availability of P... [Published Pharmacy Choice - May 16 2013]
Teva Pharmaceutical Industries Q1 net income down [Published Zecco - May 16 2013]
Alzheimer’s and Skin Cancer [Published Health Canal - May 16 2013]
Teva Jump on Actavis Widens Tel Aviv Discount: ... [Published La Repubblica - May 16 2013]
My well-off brethren, you must act now [Published Haaretz - May 16 2013]
Baby Food in Israel - New Market Report [Published Live-PR.com - May 16 2013]
Synthetic Biologics Reports First Quarter 2013 ... [Published Citybizlist - May 15 2013]
Valeant Pharmaceuticals Intl Inc (VRX), Actavis... [Published InsiderMonkey.com - May 15 2013]
Galena Targets Cancer Pain Market [Published Seeking Alpha - May 15 2013]
Following Up an Acquisition With an Even Larger... [Published Motley Fool - May 15 2013]
Actavis Seen Gaining More From Chilcott Deal Th... [Published BusinessWeek - May 15 2013]